S&P Capital IQ, a unit of The McGraw Hill Companies, completed the acquisition of London-based Credit Market Analysis Limited (CMA), a provider of independent data for the OTC markets, which the company bought from CME Group.
The sale by CME to S&P Capital IQ was part of an agreement to establish a new joint venture in the rapidly growing index business, S&P Dow Jones Indices, which also closed yesterday.
The purchase of CMA, along with several recently announced acquisitions of Toronto-based R2 Financial Technologies and Paris-based QuantHouse, enable S&P Capital IQ to obtain the components necessary to offer its clients broad market data and risk analytics platforms in the industry.
“Thousands of financial institutions around the world rely daily on CMA’s data and technology to provide them with clear, reliable pricing and related OTC information,” commented Lou Eccleston, president of S&P Capital IQ and chairman of S&P Dow Jones Indices, a new joint venture in the index business that was also established yesterday by CME and McGraw-Hill Companies. “This acquisition significantly expands S&P Capttal IQ’s asset class coverage for data and pricing and adds the technology to move into intraday quotes on derivative and other OTC securities,” added Eccleston in the release.
CMA’s clients range from some of the largest investment banks and asset managers to boutique hedge funds and risk management firms, said the company. S&P Capital IQ will integrate CMA into the company’s existing pricing and data businesses, considerably broadening the firm’s asste class coverage.